The motivation comes from the difficulty of rebuilding the highly intricate structures of the cranium, maxilla, mandible, orbital cavity and nose. Conventional repair can be limited by donor-site injury, the finite amount of available tissue and imperfect anatomical or functional matching. Craniomaxillofacial subunit transplantation, also called facial vascularized composite allotransplantation, transfers several tissue types together, including skin, mucosa, blood vessels, muscle and bone, in an attempt to replace a facial unit as a coordinated whole. This approach is anatomically feasible, but it requires lifelong immunosuppression and therefore carries the risks of rejection and medication toxicity, while also depending on a limited supply of donors. The review presents bioprinting as a possible route toward regenerative reconstruction that could reduce dependence on donor tissue.

Four-dimensional bioprinting extends conventional three-dimensional printing by adding controlled change over time. A printed construct can be compressed for delivery through a small incision and then recover a patient-specific three-dimensional shape after encountering a stimulus such as heat, moisture, altered pH or a magnetic field. This capacity could allow a scaffold to pass through a narrow surgical access route before expanding to match an irregular defect. Shape-memory polymers offer adjustable stiffness and degradation and may be useful for nerve conduits and conformal shells around non-load-bearing areas. Nickel-titanium shape-memory alloys can provide active shape recovery and superelasticity, but their non-degradability and possible nickel-ion release constrain prolonged use. Hydrogels and cell-laden bioinks are much softer, generally occupying the kilopascal range, and are more appropriate for skin, mucosa, nerve and other soft-tissue applications.

AI enters the workflow because the behavior of smart materials depends nonlinearly on composition, geometry, temperature, stress history and deformation rate. Conventional trial-and-error screening becomes especially inefficient when many formulation and structural variables must satisfy conflicting requirements. The review describes support vector regression, extreme gradient boosting, Gaussian process regression, artificial neural networks and physics-informed neural networks as tools for predicting material behavior. In one study, a Gaussian process regression model optimized processing conditions for thermally responsive microneedle patches; in a diabetic rodent model, the resulting patches produced near-complete wound closure within 10 days, with enhanced re-epithelialization and collagen remodeling. Separately, an artificial neural network reduced errors in predicting the ultimate tensile strength and shape-memory activation of a 4D-printed polymer filament by about 40% to 50% relative to linear regression and LASSO methods.

A physics-informed neural network reported in the review required only two temperature-stress curves to predict stress evolution and free-strain responses in amorphous shape-memory polymers. AI can also optimize the manufacturing process itself. A deep reinforcement-learning method tested for laser-melting path planning increased path-generation efficiency by 99.8% while reducing structural deformation by 64.0% and residual stress by 21.8%, according to the review. The authors also identify inverse design as a way to work backward from a desired anatomical outcome. Fully convolutional networks trained on more than 100,000 nonlinear finite-element datasets predicted printable mesh configurations from three-dimensional depth images with an intersection-over-union score above 90%.

Patient-specific facial structures have also been used to test the transition from computational design to physical fabrication. One dual-material system adjusted material ratios and rib-arc angles to create different deformation modes resembling a protruding nasal unit. The reported bioprinted facial masks and thin nasal shells differed from their simulation predictions by less than 10% of their overall dimensions, and transfer learning was used to extend the models from simulated data to authentic human facial anatomy. These results show feasibility within controlled settings, but they do not establish performance after implantation. Most of the models discussed were trained on finite-element simulations, leaving a possible gap between virtual predictions and the behavior of physical materials in living tissue.

Several studies in the review tested shape-adapting scaffolds in rodent bone-defect models. A dual-function scaffold with a tunable transition temperature of 37 to 42 degrees Celsius could be compressed and then triggered by near-infrared light to recover an anatomically matching shape. Hydrogel layers containing bioactive composites were intended to support stem-cell osteogenic differentiation, and the scaffold showed conformity and bone formation in rat cranial defects. Separately, a gradient alginate scaffold developed curvatures from 0.05 to 0.446 per millimeter and accelerated new bone formation in rodent models. Another PLLA scaffold containing magnetic nanoparticles recovered more than 98% of its shape within 40 seconds under external magnetic stimulation. It also suppressed NLRP3 inflammasome activation in macrophages and favored a shift from the pro-inflammatory M1 state toward the anti-inflammatory M2 state, which was associated with enhanced osteogenic differentiation of bone-marrow stromal cells.

For facial skin and cutaneous structures, programmable expanders could address the need to generate enough autologous tissue for a graft while matching an individual contour. A digital-light-processed hydrogel expander underwent programmed anisotropic buckling after contact with interstitial fluid. Five days after implantation under rat scalp skin, skin area had doubled and tissue weight had tripled without reported local injury. Patient-specific adaptive elastic hydrogel expanders were subsequently used in rabbits to create auricle-shaped skin flaps with contours closely matching native ears, while breast-shaped expanders reached an average adult diameter of about 10 centimeters and supported neovascularization in the expanded tissue. Dynamic scaffolds have also been tested for nerves: a programmed shape-memory structure combined surface microtopography with mechanical stretching, increased repair efficiency for large-segment nerve defects by 60% and produced an effect comparable to autologous nerve grafting in the reported experiments.

Long-term survival of large composite grafts depends on microvascular networks, making vascularized 4D printing a central requirement rather than a decorative addition. The review highlights a two-component alginate and methylcellulose hydrogel that produced perfusable, branched, T-shaped vascular channels with antioxidant, anti-inflammatory and antithrombotic activity; the work, however, focused on an in-vitro vascular model. A separate dual-layer periosteal construct combines osteoprogenitor cells with a collagen layer incorporating nerve and microvascular networks, with the aim of coordinating bone formation and blood-vessel development in vivo. Together with the bone, skin and nerve studies, these experiments portray a possible integrated soft-and-hard tissue system, but the evidence does not yet show that AI-designed, 4D-printed facial units can replace a living transplant in patients or eliminate the need for immunosuppression.

Major barriers remain before that goal can be tested in clinical reconstruction. The mandible experiences occlusal forces of roughly 300 to 500 newtons, whereas most shape-memory polymers have compressive moduli below 100 megapascals, making them unsuitable as permanent load-bearing implants under current formulations. Their transition temperatures must also be controlled within a narrow physiological window: values above 42 degrees Celsius may injure adjacent tissue, while values near 37 degrees Celsius can allow unwanted deformation in inflammation-associated hyperthermia. Predictable motion is similarly difficult because most deformation data come from idealized laboratory tests rather than complex, variable biological environments. Finally, AI systems require standardized multimodal datasets that are scarce, small and inconsistent, while batch differences can cause precision to be lost when computational recommendations are transferred to physical printers. The review’s proposed path forward combines region-specific composite materials, multiscale simulation, intraoperative feedback, standardized multicenter datasets and explicit measures of model uncertainty. Its conclusion is therefore prospective: AI-assisted 4D bioprinting is a credible design framework with promising laboratory results, but not yet a clinically validated alternative to established craniomaxillofacial reconstruction.

Subject of Research: Review of AI-assisted 4D bioprinting for craniomaxillofacial reconstruction

Article Title: Artificial intelligence-empowered 4D bioprinting for craniomaxillofacial subunit reconstruction: a comprehensive review

Article References: Chen, H., Zou, S., & Song, J. (2026). Artificial intelligence-empowered 4D bioprinting for craniomaxillofacial subunit reconstruction: a comprehensive review. Frontiers in Bioengineering and Biotechnology, 14, Article 1964537. https://doi.org/10.3389/fbioe.2026.1964537

Image Credits: AI Generated

DOI: 10.3389/fbioe.2026.1964537

Keywords: 4D bioprinting, artificial intelligence, craniomaxillofacial reconstruction, shape-memory polymers, biofabrication, regenerative medicine, inverse design, vascularized tissue engineering, nerve regeneration, smart materials, Artificial, intelligence-empowered

The research team, led by Wanjia Jia and colleagues at the First Affiliated Hospital of Henan University of Chinese Medicine, screened eight international databases and manually searched reference lists to identify every randomized controlled trial comparing acupuncture-based interventions with non-acupuncture therapies. After removing duplicates and screening titles, abstracts, and full texts, they included 36 trials, all published in Chinese, with a combined total of 3,282 patients. The trials covered a wide range of injuries, including brachial plexus injuries, radial nerve palsy, median nerve damage, sciatic nerve injury, and common peroneal nerve palsy. The interventions included manual acupuncture, electroacupuncture, warm needling, and acupoint injection, while the control groups received medication, rehabilitation training, physical therapy, or biofeedback.

The researchers evaluated five outcomes. The primary outcome was the clinical effective rate, a composite measure of symptom improvement and functional recovery. The secondary outcomes included the distal motor latency, the compound muscle action potential, the sensory nerve conduction velocity, and adverse reactions. When the data were pooled, the results were striking. The clinical effective rate was significantly higher in the acupuncture groups, with a relative risk of 1.24 and a 95 percent confidence interval of 1.19 to 1.30. The distal motor latency was significantly shorter, the compound muscle action potential was significantly larger, and the sensory nerve conduction velocity was significantly faster in the acupuncture groups compared with the controls.

These electrophysiological findings are particularly noteworthy because they are objective measures rather than subjective symptom reports. A shorter distal motor latency indicates that electrical signals are traveling more quickly from the stimulation site to the target muscle, which suggests that the nerve is conducting impulses more efficiently. A larger compound muscle action potential indicates that more muscle fibers are being recruited, which suggests that more motor units are functioning. A faster sensory nerve conduction velocity indicates that sensory signals are traveling more quickly, which suggests that the sensory pathways are recovering. Taken together, these measures suggest that acupuncture may be doing more than simply masking symptoms; it may be producing measurable changes in nerve function.

The subgroup analyses added further nuance. When the researchers stratified the data by injury type, the effects were consistent across brachial plexus injuries, radial nerve palsy, median nerve injuries, sciatic nerve injuries, and common peroneal nerve palsy. When they stratified by intervention type, the effects were consistent across manual acupuncture, electroacupuncture, warm needling, and acupoint injection. When they stratified by treatment duration, the effects were consistent across short-term and long-term treatment. This consistency suggests that the effects are not limited to a specific injury, intervention, or treatment duration, which strengthens the case that acupuncture may be producing genuine effects on nerve regeneration.

However, the researchers also identified significant limitations. The methodological quality of the included trials was generally low. Only a minority of trials reported adequate randomization procedures, and almost none reported allocation concealment, blinding, or preregistered protocols. The risk of bias was high across most domains, and the certainty of the evidence was low to very low for all outcomes. The researchers also noted that all 36 trials were published in Chinese, which raises questions about publication bias and the generalizability of the findings to other populations.

The researchers also performed a trial sequential analysis, a statistical method that estimates whether the accumulated evidence is sufficient to support a conclusion. The results showed that the accumulated sample size had not yet reached the required information size for most outcomes, which means that the evidence is not yet conclusive. In other words, while the pooled results are statistically significant, the accumulated evidence is not yet sufficient to rule out the possibility that the findings are due to chance or bias.

The researchers also noted that the trials used a wide range of acupuncture techniques, acupoints, and treatment durations, which makes it difficult to determine which specific approach is most effective. The control groups also received a wide range of non-acupuncture therapies, which makes it difficult to determine whether the effects are due to acupuncture itself or to the additional attention and contact that acupuncture patients receive. Almost none of the trials used sham acupuncture controls, which means that the placebo effect cannot be ruled out.

Despite these limitations, the researchers concluded that acupuncture may be a useful adjunct therapy for traumatic peripheral nerve injuries. The pooled results suggest that acupuncture produces measurable improvements in both subjective symptom reports and objective electrophysiological measures, and the consistency of the effects across injury types, intervention types, and treatment durations strengthens the case that these effects are genuine. However, the low methodological quality of the included trials, the high risk of bias, and the insufficient accumulated evidence mean that the findings should be interpreted with caution.

The researchers called for larger, better-designed randomized controlled trials with adequate randomization procedures, allocation concealment, blinding, and preregistered protocols. They also called for trials that use sham acupuncture controls to isolate the specific effects of acupuncture from the placebo effect, and for trials that use standardized acupuncture techniques to determine which specific approach is most effective. They also called for trials that include patients from other countries and populations to determine whether the findings are generalizable. Until such trials are conducted, the question of whether acupuncture actually accelerates nerve regeneration remains open, and the answer will depend on the quality of the evidence rather than the enthusiasm of the researchers.

Subject of Research: Clinical effects of acupuncture for traumatic peripheral nerve injury: a meta-analysis of randomized controlled trials

Article Title: Clinical effects of acupuncture for traumatic peripheral nerve injury: a meta-analysis of randomized controlled trials

Article References: Jia, W., Liang, R., Duan, Y., Xu, Y., Ran, X., Wang, Y., Li, C., Guo, Y., & Zhang, M. (2026). Clinical effects of acupuncture for traumatic peripheral nerve injury: a meta-analysis of randomized controlled trials. Frontiers in Neurology, 17, Article 1852669. https://doi.org/10.3389/fneur.2026.1852669

Image Credits: AI Generated

DOI: 10.3389/fneur.2026.1852669

Keywords: acupuncture, peripheral nerve injury, nerve regeneration, meta-analysis, evidence-based medicine, neurorehabilitation, Clinical, effects, traumatic, peripheral, nerve, injury

The trial enrolled ninety patients with focal, mechanically caused peripheral nerve injuries — the kind produced by crush trauma, traction, lacerations, or chronic compression syndromes such as carpal tunnel and cubital tunnel disorder. Participants were randomly divided into three equal groups of thirty. One group underwent neurolysis surgery alone, a second took methylcobalamin tablets at 0.5 milligrams three times daily, and the third received both interventions. Every patient also followed the same standardized rehabilitation program, and all groups completed two consecutive thirty-day treatment courses before their sixty-day assessments.

The headline result was striking. The combination group achieved a total effective rate of 86.67 percent, meaning most patients in that group showed clear grade improvements on the Carroll Upper Extremity Function Test, a validated zero-to-ninety-nine scale of hand and arm function. By contrast, the neurolysis-only group reached 50.00 percent and the methylcobalamin-only group 53.33 percent. Ten patients in the combination arm were classified as fully cured, compared with four in the surgery group and five in the vitamin group, and only four combination patients remained in the ineffective category.

Objective electrophysiological measurements told the same story. Using nerve conduction studies, the researchers tracked motor conduction velocity, sensory conduction velocity, compound muscle action potential amplitude, and latency. While all three groups improved significantly from baseline, the combination group posted the largest gains across every parameter. Motor conduction velocity, for example, rose from roughly 38 meters per second at baseline to nearly 50 meters per second after treatment in the combined arm, versus gains of about six meters per second in each monotherapy group. Faster conduction and higher amplitudes signal restored axonal integrity and improved myelination — the biological substrate of real-world function.

Those electrical improvements translated into movement. Active and passive joint range of motion, measured with a goniometer, improved in all groups but soared in the combination arm: active range of motion climbed from about 10.5 degrees to 42.2 degrees, and passive range of motion from about 24 degrees to nearly 63 degrees, roughly double the gains seen in either monotherapy group. Pain scores on the Global Pain Scale, which covers clinical symptoms, emotional state, daily activities, and pain intensity, fell in every group, but the combination group recorded the lowest post-treatment scores in all four domains.

Blood tests added a biochemical dimension to the findings. The researchers measured serum levels of three inflammatory mediators — nuclear factor kappa B (NF-κB), tumor necrosis factor-alpha (TNF-α), and interleukin-6 (IL-6) — using enzyme-linked immunosorbent assays on fasting blood samples. All three markers dropped after treatment in every group, but the combination group achieved the deepest suppression: NF-κB fell to 13.76 micrograms per liter, TNF-α to 16.45 micrograms per liter, and IL-6 to 6.37 picograms per milliliter, all significantly lower than in either monotherapy arm. The trial also reported markedly lower rates of limb numbness, joint stiffness, chronic pain, and limb atrophy among combination patients.

The logic behind the synergy is biologically coherent. Neurolysis is a mechanical fix: surgeons meticulously free the injured nerve from scar tissue, adhesions, or fibro-osseous tunnels, restoring its ability to glide and re-establishing blood supply. But surgery alone does little to correct the hostile biochemical environment inside the damaged nerve, where inflammatory cascades perpetuate injury and stall regeneration. Methylcobalamin works from the opposite direction. As the neuroactive form of vitamin B12, it supports axonal regeneration, promotes myelin synthesis, sustains neuronal survival, and — as prior research has shown — inhibits NF-κB signaling and the downstream cytokines that drive neuropathic pain. What it cannot do is physically decompress a nerve trapped in constrictive scar tissue.

The trial’s methodology deserves attention. It was prospective, randomized, and evaluator-blinded: an independent statistician generated the allocation sequence using permuted blocks, assignments were concealed in sequentially numbered opaque envelopes, and all outcome assessments — functional testing, nerve conduction studies, range-of-motion measurements, pain scoring, and laboratory analyses — were performed by assessors blinded to group allocation. Patients and surgeons could not be blinded to surgery, but the intention-to-treat analysis and blinded data handling reduce the risk of detection bias. The sample size was determined a priori by power analysis, and baseline characteristics, injury etiologies, and severity were balanced across the three groups.

The authors are candid about limitations. The study was single-center, so results may not generalize to other populations or surgical teams. The follow-up window was only sixty days, which captures early recovery but says nothing about long-term durability, symptom recurrence, or late complications. The patient cohort mixed several injury subtypes, and subtle variations in surgical technique and rehabilitation adherence are unavoidable in clinical practice. Larger, multicenter trials with follow-up of twelve months or longer, homogeneous injury groups, and optimized methylcobalamin dosing regimens will be needed before the combined approach can be considered a standard of care.

Even with those caveats, the findings carry real weight for a condition that has long lacked rigorous comparative evidence. Traumatic peripheral nerve injuries affect an estimated 13 to 23 people per 100,000 each year, and the resulting disability and chronic pain impose heavy personal and economic costs. If the synergy holds up in larger trials, the message for clinicians would be straightforward: mechanical decompression and pharmacological neuroprotection are not competing strategies but complementary halves of the same problem. Freeing the nerve gives it room to heal; feeding it methylcobalamin helps it actually regenerate. The combination, this trial suggests, is more than the sum of its parts.

Subject of Research: Combined neurolysis surgery and methylcobalamin therapy for peripheral nerve injury recovery

Article Title: Synergistic efficacy of combined neurolysis and methylcobalamin in peripheral nerve injury: a randomized clinical trial

Article References: Hu, X., & Li, Z. (2026). Synergistic efficacy of combined neurolysis and methylcobalamin in peripheral nerve injury: a randomized clinical trial. Frontiers in Integrative Neuroscience, 20, Article 1747898. https://doi.org/10.3389/fnint.2026.1747898

Image Credits: AI Generated

DOI: 10.3389/fnint.2026.1747898

Keywords: peripheral nerve injury, neurolysis, methylcobalamin, vitamin B12, nerve conduction, inflammation, NF-κB, TNF-alpha, IL-6, randomized clinical trial, neuropathic pain, nerve regeneration

Electrical stimulation has long been known to enhance peripheral nerve repair, but conventional stimulators require external electrodes and power supplies that complicate clinical use and often demand surgical removal. The review highlights how biodegradable nanogenerators sidestep these limitations by generating stimulation locally, from within the implant itself, and by degrading safely once their therapeutic mission is complete. Galvanic platforms rely on the electrochemical potential between dissimilar metals such as magnesium and molybdenum, producing a steady direct-current electric field of roughly 10 to 100 millivolts per millimeter. Triboelectric devices exploit contact electrification between polymer layers, while piezoelectric platforms generate charge from mechanical deformation of crystalline materials such as polyvinylidene fluoride or polylactic acid.

The review traces the evolution of these devices from early proof-of-concept implants to sophisticated platforms capable of matching autologous nerve grafting in rodent models. A 2020 study reported a fully biodegradable galvanic nerve conduit that produced a steady direct-current field across a 15-millimeter defect in rat sciatic nerve, achieving functional recovery comparable to autologous nerve grafting at 12 weeks. Subsequent work introduced triboelectric platforms that harvest energy from the rhythmic deformation of surrounding tissue, generating alternating-current output that enhanced nerve regeneration across 15-millimeter defects. Piezoelectric conduits have progressed from simple polymer films to multilayered composites incorporating conductive nanofillers, with some platforms achieving functional recovery across 15-millimeter defects at 12 weeks.

The review emphasizes that the therapeutic benefit of these devices depends on far more than raw electrical output. Loaded dose, waveform, frequency, and electrode geometry all shape the biological response, and the review argues that researchers must calibrate these parameters against the specific regenerative context being evaluated. The review also distinguishes the direct electrical stimulation provided by these devices from the indirect mechanical effects of the implant itself, noting that the two can be evaluated separately in controlled experiments. The review further highlights how the biological response varies across the regenerative timeline, with early-phase enhancement of nerve regeneration differing from late-phase effects on functional recovery.

The review identifies galvanic platforms as particularly promising for clinical translation, given their steady direct-current output and their ability to match autologous nerve grafting in rodent models. Triboelectric devices offer the advantage of harvesting energy from the body’s own rhythmic motion, generating alternating-current output that can be tuned to the regenerative context. Piezoelectric conduits have progressed from simple polymer films to sophisticated multilayered composites, with some platforms achieving functional recovery across 15-millimeter defects at 12 weeks. The review argues that the next generation of these devices must integrate wireless activation, calibrated electrical dosing, and safe biodegradation to translate the rodent-model success into clinical practice.

The review concludes that biodegradable nanogenerators represent a promising path toward nerve repair that matches autologous nerve grafting without the limitations of external power sources. The review argues that the next generation of these devices must integrate wireless activation, calibrated electrical dosing, and safe biodegradation to translate the rodent-model success into clinical practice. The review further highlights how the biological response varies across the regenerative timeline, with early-phase enhancement of nerve regeneration differing from late-phase effects on functional recovery. The review concludes that biodegradable nanogenerators represent a promising path toward nerve repair that matches autologous nerve grafting without the limitations of external power sources.

Understanding why electrical cues matter for nerve repair requires looking at what happens inside the injured nerve itself. After a traumatic transection or severe crush, the segment of axon distal to the wound undergoes Wallerian degeneration, a coordinated dismantling process in which the internal cytoskeleton breaks apart and Schwann cells shift from their normal myelinating role into an activated repair state. These repair-phase Schwann cells proliferate and line up inside the residual basal lamina tubes, forming the Bands of Büngner that serve as physical guide rails for regenerating axonal sprouts, while macrophages recruited to the site clear away axonal and myelin debris. Schwann cells also secrete growth factors such as nerve growth factor and glial cell-derived neurotrophic factor, and endothelial cells and fibroblasts help preserve the structural framework of the nerve. Yet even with this endogenous repair machinery in place, axons regrow at only about one to three millimeters per day, and prolonged regeneration allows the repair Schwann cells to lose their activated phenotype, the guidance tubes to collapse, and denervated muscle fibers to atrophy irreversibly.

Exogenous electrical stimulation acts on this repair cascade at several points. At the cellular level, electrical cues influence neuronal membrane polarization and promote calcium influx through voltage-gated calcium channels, setting off downstream signaling through pathways including PI3K/Akt, MAPK/ERK, focal adhesion kinase, and the mechanotransductive regulator YAP. The resulting ion-influx signaling encourages neurite extension, Schwann cell proliferation and migration, secretion of neurotrophic factors, and context-dependent macrophage responses. Electrical stimulation also upregulates regeneration-associated genes such as GAP-43 and enhances BDNF/TrkB signaling through calcium-dependent cAMP signaling. Clinical studies have explored brief perioperative stimulation protocols, such as one hour at 20 hertz, and reported improvements in selected electrophysiological measures of reinnervation, although improved electrophysiology has not always translated into improved functional recovery, a gap that underscores how carefully dosing and outcome measurement must be matched.

The way electrical energy reaches the tissue differs substantially across delivery methods, and this distinction shapes both device design and biological effect. Direct coupling approaches place direct-current or alternating-current electrodes in contact with or implanted within the target nerve, delivering stimulation through physical conduction. Indirect coupling approaches, including capacitive coupling and pulsed electromagnetic fields, generate a homogeneous electromagnetic field between electrodes or convert electromagnetic energy into pulsed stimuli that mimic the body’s own electrophysiological rhythms, inducing electrical effects within cells without direct contact. Each mode carries different implications for electrode geometry, field uniformity, and the degree to which the stimulus can be localized to the repair site rather than dissipating through surrounding tissue.

Conventional electrical stimulation systems, however, depend on externally powered electrodes connected through percutaneous leads or on implantable pulse generators containing rigid, non-degradable batteries. These configurations introduce meaningful clinical risks, including infection and chronic foreign-body inflammation at the hardware site, and they typically require a second invasive surgery to remove the device once therapy is complete. The burden of repeated operations, combined with the challenge of powering implanted electronics over the long regeneration timeline, has motivated the search for self-powered alternatives that draw their energy from the biological environment itself rather than from an external supply.

Among the self-powered strategies, enzymatic biofuel cells have been investigated as a way to harvest energy from physiological chemistry, but their application to neural repair remains constrained by enzyme instability and low power density, limiting their practical utility in this context. By contrast, galvanic, triboelectric, and piezoelectric platforms have each accumulated preclinical evidence in peripheral nerve models, and the review organizes these three approaches within a common analytical framework spanning material selection, device architecture, stimulation characteristics, and biological outcomes. Rather than ranking technologies by unloaded voltage or other isolated device-level metrics, the review emphasizes stimulation dose, experimental conditions, regenerative endpoints, degradation behavior, safety, and translational requirements as the criteria that matter for clinical relevance.

The broader shift in neuroengineering over the past decade reflects a movement away from passive structural bridging toward active, self-powered bioelectronic neuromodulation. This evolution draws on advanced materials science and electrical engineering to develop therapeutic approaches for neurological disorders beyond peripheral nerve repair, including spinal cord, vagus nerve, and sciatic nerve stimulation. The convergence of biodegradable materials with energy-transduction mechanisms represents a departure from earlier generations of nerve guidance conduits made from collagen, polyglycolic acid, or poly(lactic-co-glycolic acid), which provided structural support but could not deliver the dynamic biochemical and bioelectrical cues needed to accelerate axonal elongation, sustain Schwann cell activity, and prevent denervation-induced muscle atrophy.

Establishing the clinical value of self-powered electroactive platforms ultimately depends on demonstrating the delivered stimulation dose with precision, confirming long-term safety as the device degrades, and reproducing functional benefit across independent studies and animal models. The review’s translational framework connects the physics of energy harvesting and device design to the strength of regenerative evidence, aiming to distinguish demonstrated biological effects from device-level performance claims. By framing the comparison around how the energy source and device architecture determine the nature, duration, and controllability of the electrical stimulus, and how those parameters relate to cellular responses and functional outcomes, the review offers a structured basis for evaluating which self-powered platforms are most likely to advance from rodent models toward clinical application in peripheral nerve repair.

Subject of Research: Biodegradable nanogenerators for peripheral nerve repair

Article Title: Self-powered bioelectronics for peripheral nerve regeneration: Electroactive materials, energy transduction, and therapeutic mechanisms

Article References: Kao, F.-C., Pebam, M., Parashar, P., Wang, S.-F., Chiu, P.-Y., Tsai, T.-T., Niu, C.-C., Chen, S.-H., Choi, D., Hsieh, M.-K., & Lin, Z.-H. (2026). Self-powered bioelectronics for peripheral nerve regeneration: Electroactive materials, energy transduction, and therapeutic mechanisms. Materials Today Bio, 41, Article 103734. https://doi.org/10.1016/j.mtbio.2026.103734

Image Credits: AI Generated

DOI: 10.1016/j.mtbio.2026.103734

Keywords: biodegradable nanogenerators, peripheral nerve repair, galvanic cells, triboelectric nanogenerators, piezoelectric nanogenerators, electrical stimulation, nerve regeneration, autologous nerve grafting, Self-powered, bioelectronics, peripheral, nerve

The retraction notice itself contains an unusual element worth pausing over: the journal states that the manuscript “requires substantial revisions that go beyond the scope of a standard correction” and that retraction was chosen “to allow for a comprehensive revision and resubmission.” This framing sits somewhat awkwardly with standard publishing norms, in which retraction is generally understood as a permanent withdrawal of a paper from the scientific record, not a temporary holding state. In conventional practice, a paper that needs revision before its claims can be trusted would typically receive an editorial expression of concern, a correction, or, in the most serious cases, retraction without the expectation of resubmission. The suggestion that a retracted paper might return in revised form is rare, and readers who encounter the original 2023 article in databases or citation lists should understand that, as of the retraction notice, the paper’s findings cannot be relied upon regardless of whether a revised version ever appears.

The technical concerns that triggered the retraction centered on image integrity, specifically duplications identified in Figures 3B and 4D of the original paper. Image duplication is one of the most commonly cited categories in post-publication scrutiny of the life sciences, and it can arise in several distinct ways. Sometimes the same microscopy field or blot image is inadvertently presented twice, for example when a control panel is mistakenly reused in an experimental condition panel. In other cases, duplication reflects systematic problems with how data were generated, selected, or assembled, which raises deeper questions about the reliability of the entire dataset. The retraction notice does not specify which scenario applies here, and the fact that the journal concluded the problems required “substantial revisions” rather than a simple correction suggests the issues were not trivially confined to a mislabeled panel. Without access to the underlying raw data, readers cannot determine how far the duplications extend or whether the central conclusions about miR-214, PTEN, and the JAK2/STAT3 pathway would survive a careful reanalysis.

The authors’ silence adds another layer of concern. The notice states plainly that the authors “have not responded to correspondence regarding this retraction.” In the standard workflows recommended by the Committee on Publication Ethics, editors are expected to seek the authors’ response to integrity concerns before acting, and a cooperative process often produces a correction or clarification that preserves most of a paper’s value. When authors fail to engage, editors must proceed on the available evidence, and the resulting notices tend to be more categorical. Non-response also deprives the scientific community of context that only the authors could provide, such as whether original image files exist, whether the duplications stem from assembly errors, and whether the key experiments can be repeated from archived samples. For a paper whose central claim rests on a chain of molecular interactions in a living tissue model, that lost context is not easily reconstructed by outsiders.

It is worth considering what the original paper claimed, because the scientific premise remains interesting even as the published evidence is now withdrawn. Peripheral nerve injuries are common, ranging from traumatic lacerations and crush injuries to compression neuropathies, and while the peripheral nervous system retains a genuine capacity for regeneration unlike the central nervous system, that capacity is slow and often functionally incomplete. Axons regrow at roughly a millimeter per day under favorable conditions, and the quality of recovery depends on factors including the distance the regenerating axon must travel, the degree of scarring at the injury site, the survival and activation of Schwann cells that guide and support regrowth, and the timely reinnervation of target muscle, which deteriorates the longer the muscle remains denervated. Any intervention that reliably accelerates or improves the completeness of regeneration would address a substantial unmet clinical need, which is why the field has explored approaches ranging from surgical grafting techniques and nerve guides to electrical stimulation, pharmacological agents, and cell-based therapies.

Exosomes sit within a broader family of extracellular vesicles that cells release naturally, and they have attracted intense interest as mediators of intercellular communication and as candidate therapeutics. Unlike whole-cell transplantation, exosome-based approaches avoid some of the practical obstacles that complicate cell therapy, including immune rejection of transplanted cells, risks of uncontrolled proliferation or inappropriate differentiation, and the logistical challenges of manufacturing, storing, and delivering living cells to the site of injury. Exosomes carry proteins, lipids, and nucleic acids, including microRNAs, from their cell of origin, and accumulating evidence suggests that a meaningful fraction of the regenerative effects attributed to transplanted stem cells may actually be mediated by the vesicles those cells secrete rather than by the cells themselves engrafting and integrating into tissue. This has motivated efforts to isolate exosomes from various stem cell sources, characterize their cargo, and in some cases engineer them to carry elevated levels of specific therapeutic molecules.

MicroRNA-214, the cargo highlighted in the retracted study, is a small regulatory RNA with documented roles in multiple biological processes, including muscle biology, where it was originally characterized as a myogenic regulator, as well as in fibrosis, inflammation, and cell survival. Its proposed relevance to nerve repair in the retracted paper rested on the idea that delivering extra copies of this microRNA to injured nerve tissue would suppress PTEN, a gene encoding a well-known phosphatase that acts as a brake on the PI3K/AKT growth-signaling pathway. PTEN is famous in regeneration biology because its suppression in neurons can enhance axonal growth, an effect demonstrated in central nervous system neurons where intrinsic regenerative capacity is otherwise very limited. The retracted paper extended this logic to the peripheral nerve setting and added a second layer, claiming that the resulting signaling cascade activated the JAK2/STAT3 pathway, a signaling axis involved in cytokine responses, cell survival, and proliferation that has been implicated in Schwann cell activation and repair-associated glial phenotypes. The appeal of the design was that a single engineered vesicle payload could, in principle, coordinate multiple pro-regenerative programs at once.

That mechanistic elegance is precisely why the retraction matters beyond the fate of one paper. If the image-level concerns undermine the experimental evidence for the miR-214–PTEN–JAK2/STAT3 axis in this context, other groups considering follow-up work lose the foundation they would have built on. Conversely, if the underlying biology is sound and only the presentation of data was flawed, the field loses a potentially useful therapeutic concept to a preventable failure of research practice. Either way, the episode illustrates how dependent the microRNA and extracellular vesicle literature is on the integrity of relatively small, hard-to-verify datasets. MicroRNA functional studies typically rely on gain- and loss-of-function experiments, reporter assays, and downstream pathway readouts, and image-based figures such as immunoblots, histological sections, and fluorescence micrographs carry much of the evidentiary weight. When panels within such figures are duplicated, the reader cannot tell whether independent biological replicates actually support the claimed effects.

The timeline of the case is also instructive. The original article was published on 26 May 2023, and the retraction notice was received on 8 October 2026, accepted the same day, and published on 16 October 2026. More than three years therefore elapsed between publication and retraction. Such intervals are not unusual in research integrity cases, which often require extensive correspondence, image forensics, consultation with institutional officials, and internal editorial review, but they highlight a structural challenge for the scientific literature: during the intervening years, the paper remained indexed, citable, and potentially influential. Readers who cited or built on the work during that period had no signal that concerns existed. The rapid acceptance of the retraction once it entered the editorial pipeline, received and accepted on the same day, suggests the deliberation had largely concluded before the formal notice was processed, with the approval of the journal’s Chief Editors and the Chief Executive Editor providing the final authorization.

For readers assessing the broader literature on stem cell exosomes and nerve repair, several practical lessons follow. First, retracted papers should be treated as withdrawn from the evidentiary base, and citation databases increasingly flag them, but manual literature reviews can still surface retracted work without warning, so checking retraction status remains essential when drawing on older studies. Second, the specific combination of claims in this paper, involving engineered exosome cargo, a targeted tumor suppressor, and a canonical signaling pathway, represents a pattern common in the regenerative medicine literature, where mechanistic narratives are assembled from multiple molecular links. Each link depends on its own experiments, and integrity problems in any part of the chain can compromise the whole. Third, the fact that the journal framed retraction as a prelude to possible resubmission means that any future revised version of this work would need to be evaluated on its own merits, with fresh scrutiny of the data, rather than being accepted as a continuation of the original paper’s findings. Until and unless such a revised study appears and passes independent review, the claim that miR-214-enriched muscle-derived stem cell exosomes promote sciatic nerve regeneration through PTEN targeting and JAK2/STAT3 activation should be regarded as unsupported by peer-reviewed evidence.

Finally, the case underscores the role of post-publication vigilance in modern science. The concerns here were raised after publication, presumably by readers or reviewers who noticed the duplicated images, and the journal’s response, culminating in a formal retraction approved at the highest editorial level, reflects the increasing willingness of publishers to act on integrity issues even years after the fact. For a field as clinically motivated as peripheral nerve regeneration, where patients and clinicians await genuinely effective therapies, maintaining a trustworthy record of what has and has not been demonstrated is not an administrative formality but a prerequisite for progress.

Subject of Research: Neuroscience

Article Title: Retraction: Muscle-derived stem cell exosomes with overexpressed miR-214 promote the regeneration and repair of rat sciatic nerve after crush injury to activate the JAK2/STAT3 pathway by targeting PTEN

Article References: Frontiers Editorial Office (2026). Retraction: Muscle-derived stem cell exosomes with overexpressed miR-214 promote the regeneration and repair of rat sciatic nerve after crush injury to activate the JAK2/STAT3 pathway by targeting PTEN. Frontiers in Molecular Neuroscience, 19, Article 2021959. https://doi.org/10.3389/fnmol.2026.2021959

Image Credits: AI Generated

DOI: 10.3389/fnmol.2026.2021959

Keywords: exosomes, miR-214, sciatic nerve, peripheral nerve injury, JAK2/STAT3, PTEN, muscle-derived stem cells, nerve regeneration, microRNA, rat model, regenerative medicine, cell-free therapy

The biological response to peripheral nerve injury is highly intricate and comprises a synchronized sequence of cellular and molecular processes, including Wallerian degeneration, Schwann cell stimulation, macrophage-dependent debris removal, vascularization, extracellular matrix remodeling, and axonal regeneration. Successful recovery relies not only on the inherent regenerative capability of peripheral nerves but also on the reestablishment of a permissive niche facilitating neural healing. In the mandibular canal, however, regeneration may be impaired by distinct anatomical limitations. Edema, vascular inadequacy, inflammation, and fibrosis can compromise axonal regrowth and contribute to persistent neurosensory disturbance. Consequently, functional recovery after IAN injury is largely unpredictable, underscoring the need for therapeutic strategies that actively facilitate regeneration rather than merely attenuating symptoms.

Contemporary management approaches for IAN injury remain mainly supportive. Corticosteroids are mostly used during the acute phase to alleviate edema and inflammation, while microsurgical interventions, pharmacologic neuroregulators, and local anesthetics are administered in some cases. Although these strategies may mitigate secondary injury or enhance symptom control, they do not directly address the multifactorial biological signaling regulating nerve regeneration. As a result, treatment outcomes remain variable, and no universally accepted regenerative treatment has emerged for daily clinical application.

Recently, regenerative peptides have garnered attention as promising biologic regulators of tissue healing and neural regeneration. Contrary to traditional treatments that target isolated components of the injury pathway, numerous peptide-mediated agents demonstrate pleiotropic activities that affect several regenerative cascades concurrently. Preclinical studies suggest that Body Protection Compound-157 (BPC-157) may enhance cytoprotection, endothelial stability, and angiogenesis while regulating inflammatory pathways. Similarly, TB-500, a derivative of thymosin β4, has been associated with enhanced cellular migration, cytoskeletal remodeling, and tissue healing in experimental models. ARA-290 has shown tissue-protective and immunoregulatory features in preclinical and selected early clinical studies. Nonetheless, these mechanisms have not been directly shown in patients with IAN injury and should be regarded as biologically plausible hypotheses rather than established clinical mechanisms.

A recent case report published in Frontiers in Oral Health presents three clinical cases of IAN injury managed with a multimodal peptide-mediated approach comprising peptide agents, adjunctive dexamethasone, and local anesthesia. The first case involved a 38-year-old female with a prior history of Le Fort orthognathic surgery who experienced failure of a dental implant at site #30, related to cyst formation, localized bone necrosis, and abscess formation. Within 24 hours after reimplantation, she reported right-sided mandibular paresthesia. CBCT imaging revealed that the implant was placed in proximity to the IAN canal, nearly 2 mm away, without direct canal violation. The clinical findings were consistent with an indirect IAN injury, possibly associated with compression, edema, or local inflammatory responses rather than direct nerve transection.

The second case involved an 85-year-old patient who experienced failure of a dental implant at site #30. The implant was extracted utilizing a trephine bur, and the osteotomy site was grafted with platelet-rich fibrin. Within 24 hours post-surgery, the patient reported right-sided mandibular paresthesia extending from the chin to the ipsilateral oral commissure. CBCT imaging showed that the osteotomy site was in proximity to the IAN canal, around 2 mm away, with no indication of direct canal penetration. The observations indicated a compression-associated or indirect IAN injury. The third case involved a 48-year-old female who presented after extraction of a tooth and subsequent bone grafting in the right posterior mandible. Postoperatively, she reported enduring numbness on the right side of the mandible, affecting the lower lip and chin. Periapical and panoramic radiographs showed tooth-related pathology directly associated with the IAN canal before extraction, reflecting a potentially more severe injury pattern.

All three patients received weekly localized intraoral submucosal infiltrations over a period of 4 weeks, utilizing the same multimodal protocol consisting of peptide agents (ARA-290 [4 mg], TB-500 [10 mg], and BPC-157 [1 mg]) together with dexamethasone (8 mg) and bupivacaine 0.5% with 1:200,000 epinephrine (3.6 mL). Injections were precisely targeted to the affected sensory distribution. During follow-up, all three patients reported gradual enhancement in neurosensory symptoms. In the first case, the previously documented area of paresthesia had substantially decreased, with only a minor residual region of hypoesthesia (almost 3 mm) persisting inferior to the vermilion border of the lower lip. In the second case, the paresthetic region had significantly diminished in size, with only a minor residual area of diminished sensation (nearly 2 mm) persisting at the lateral aspect of the chin. In the third case, the subjective numbness had diminished by nearly 95%, with almost complete resolution of the affected region. A six-month follow-up revealed satisfactory hard tissue repair, and functional recovery was adequate to enable the placement of dental implants in the previously affected area without complications. No treatment-associated adverse events were documented in any of the three cases.

Despite these promising findings, numerous alternative interpretations must be considered. Spontaneous recovery is a well-established phenomenon after minor IAN injury, especially in instances of limited axonotmesis and neuropraxia. Hence, it remains indeterminate to what extent the documented recovery was due to intervention rather than the inherent healing trajectory. Additionally, the multimodal essence of the approach impedes the detection of the contribution of any singular element. The observable advantages may stem from one agent, a subset of agents, or associations among several treatments. The likelihood of observer bias and placebo effects must also be recognized, especially since outcome evaluation depended mainly on clinical assessment and patient-documented sensory enhancements. Since this was an uncontrolled observational case series, these outcomes should not be interpreted as evidence of intervention efficacy. Spontaneous recovery, placebo effects, regression to the mean, variability in injury severity, and the simultaneous use of dexamethasone and local anesthetic all represent plausible alternative explanations for the observed clinical course.

Many limitations require recognition. The limited sample size, absence of a control group, and non-randomized treatment allocation are significant constraints. An additional limitation is the absence of standardized quantitative neurosensory evaluation. Recovery was mainly assessed using routine clinical examination, patient-reported changes in sensation, and serial photographic documentation. Objective examinations, such as validated patient-reported outcome measures, visual analog pain scores, electrophysiological studies, quantitative sensory testing, thermal discrimination, pin-prick testing, two-point discrimination, and static light-touch testing, were not obtained prospectively. Hence, the magnitude of sensory recovery cannot be objectively quantified or directly compared with other published studies using standardized neurosensory outcome measures. Another important limitation is the inability to isolate the effects of the peptide components from those of adjunctive therapy. All three patients received an identical multimodal protocol, making it impossible to determine whether the observed clinical course resulted from one agent, a combination of agents, associations among interventions, or the expected natural history of recovery. Moreover, follow-up duration was inconsistent, restricting evaluation of long-term stability. Furthermore, the long-term safety profiles, pharmacokinetics, optimal dosing approaches, and regulatory status of many peptide-mediated agents remain inadequately characterized.

Future investigations should emphasize prospective controlled trials assessing peptide-mediated regenerative approaches in patients with well-characterized IAN injuries. Longer follow-ups, imaging-dependent evaluation, quantitative sensory assessments, and standardized neurosensory outcome measures will be required to identify whether these interventions offer a significant advantage beyond traditional management and spontaneous healing. Finally, comparative studies assessing isolated versus combination peptide interventions may facilitate clarifying potential synergistic impacts and determining optimal therapeutic strategies. The present study describes three patients with IAN injury who experienced neurosensory recovery during follow-up after receiving a multimodal peptide-mediated protocol. Because of the uncontrolled observational design, lack of randomization, blinding, standardized neurosensory evaluation, and untreated controls, these findings should not be interpreted as evidence of treatment efficacy or causality. Rather, these cases represent hypothesis-generating clinical observations that support further prospective controlled trials assessing the biological rationale and potential role of regenerative peptide-mediated strategies in the management of IAN injury.

Subject of Research: Regenerative peptides as adjuncts for inferior alveolar nerve injury repair

Article Title: Case Report: Regenerative peptides for Inferior alveolar nerve injury: a narrative review with hypothesis-generating three clinical cases

Article References: Froum, S., Estrin, N., Pico, G., Yakubov, M., Ahmad, P., & LaValle, J. (2026). Case Report: Regenerative peptides for Inferior alveolar nerve injury: a narrative review with hypothesis-generating three clinical cases. Frontiers in Oral Health, 7, Article 1907109. https://doi.org/10.3389/froh.2026.1907109

Image Credits: AI Generated

DOI: 10.3389/froh.2026.1907109

Keywords: inferior alveolar nerve, regenerative peptides, BPC-157, TB-500, ARA-290, nerve regeneration, oral and maxillofacial surgery, dental implants, case report, neurosensory recovery, Case, Report

ROS are chemically reactive molecules derived from oxygen metabolism, including superoxide anion, hydroxyl radical, and hydrogen peroxide. Under physiological conditions, the cell’s endogenous antioxidant systems maintain an exquisite balance between ROS generation and scavenging. But after peripheral nerve injury, combined cellular damage and inflammation exacerbate leakage from the mitochondrial electron transport chain, while enzymes of the NADPH oxidase family and oxidative bursts during ischemia-reperfusion injury pour out additional ROS. When production overwhelms antioxidant defenses, oxidative stress ensues, and its harmful effects can overshadow the beneficial ones—inducing apoptosis, activating inflammation, and disrupting the environmental stability that regenerating nerves depend on.

The central paradox highlighted by the review is that ROS are not simply toxic byproducts. A moderate increase in ROS after injury actually promotes the proliferation and differentiation of Schwann cells and participates in signal transduction. Injury-induced hydrogen peroxide, for example, acts as a pro-regenerative signal: research cited in the review shows that it activates ERK1/2 and c-Jun to drive Schwann cell phenotype conversion, while simultaneously upregulating the gene Ctgf through the YAP/TEAD pathway to remodel the extracellular matrix in ways that guide Schwann cell migration and oriented axonal growth. Low concentrations of ROS also serve as redox signaling molecules that regulate cell proliferation, differentiation, and other basic life activities, and immune cells harness ROS bursts to clear pathogens during the inflammatory response.

Excessive ROS, however, pushes Schwann cells toward a senescent-like state that dismantles the regenerative microenvironment. The review details how oxidative damage begins with the polyunsaturated fatty acids in the Schwann cell membrane, the primary targets of ROS attack. Lipid peroxidation disrupts membrane integrity, and accumulated lipid peroxides cause neurological changes such as axonopathy and demyelination. Crucially, sustained oxidative stress can progress to ferroptosis, an iron-dependent form of cell death. Excessive ROS rapidly depletes intracellular glutathione, which inactivates glutathione peroxidase 4, the enzyme responsible for neutralizing toxic lipid hydroperoxides. The Fenton reaction, triggered by hydrogen peroxide and ferrous ions, then initiates lipid peroxidation that ruptures the cell membrane, while the enzyme ACSL4 exacerbates the damage by enriching the membrane with the very fatty acids most prone to peroxidation.

Oxidative stress also undermines Schwann cell function through more indirect routes. It inhibits proliferation in a dose-dependent manner, suppresses the secretion of neurotrophic factors such as brain-derived neurotrophic factor and nerve growth factor, and degrades key extracellular matrix components like laminin and fibronectin that provide the physical scaffolding for axonal regeneration. At the molecular level, cell fate hinges on a dynamic equilibrium between pro-survival pathways—Nrf2/ARE, MAPK/ERK, PI3K/Akt, and NF-κB—and pro-apoptotic pathways including JAK/STAT, ATM/p53, and MAPK/JNK/p38. Excessive ROS tips this balance toward apoptosis by boosting pro-apoptotic proteins such as Bax and Caspase-3, and it can arrest Schwann cells in the G0/G1 phase, leaving them quiescent or senescent and unable to clear myelin debris, secrete trophic factors, or support axon regrowth.

Schwann cells are not passive victims. The review describes a layered endogenous antioxidant arsenal. Damaged mitochondria are sequestered and degraded through mitophagy pathways involving PINK1/Parkin, BNIP3/NIX, and FUNDC1, limiting further ROS production. The AMPK and mTOR pathways bidirectionally regulate macroautophagy according to nutrient availability, sustaining cellular survival under energy stress. Enzymatic defenses—superoxide dismutase, catalase, and glutathione peroxidase—convert ROS into non-toxic metabolites, while non-enzymatic antioxidants such as vitamins C, E, and A, melatonin, and glutathione directly neutralize reactive species. Together these systems regenerate and recycle antioxidant enzymes, establishing a sustainable cycle of defense.

The translational centerpiece of the review is a new generation of nerve guidance conduits engineered around this oxidative axis. Traditional scaffolds are single-function designs that cannot respond to the dynamic changes of the regenerative microenvironment, and most FDA-approved conduits remain passive hollow tubes that perform well only for short defects under three centimeters. The emerging paradigm integrates living cells, scaffold matrices, and bioactive signaling factors into three-dimensional constructs that actively direct axon growth. Pore architecture matters enormously: sufficiently large, interconnected channels promote vascular ingrowth and nutrient exchange, reversing the energy depletion that oxidative stress imposes on Schwann cells, while excessively small pores act as physical barriers that starve cells and heighten their susceptibility to ferroptosis. Ideal conduits therefore adopt graded or composite pore structures, exemplified by multichannel GelMA hydrogels with 200-micrometer main channels and fiber scaffolds with nanoscale grooves that guide directional Schwann cell migration.

Material selection has evolved in parallel. Natural polymers such as chitosan and hyaluronic acid offer excellent biocompatibility—one composite conduit combining the two promoted Schwann cell proliferation while suppressing fibroblast overgrowth and scar formation—whereas synthetic polymers like polycaprolactone provide superior mechanical strength for long-gap repairs. Composite designs reconcile these trade-offs, as in mineralized collagen conduits that boost compressive strength without sacrificing bioactivity. Conductive scaffolds add another dimension: graphene-based composites establish three-dimensional electrical networks that promote coupling among Schwann cells, while their abundant π-electron clouds efficiently scavenge hydroxyl radicals, achieving simultaneous electrical conductivity and antioxidant capacity. Weak electrical signals from such scaffolds also activate endogenous calcium signaling and FAK/AKT pro-survival pathways, reversing oxidative suppression of neurotrophic factor secretion.

Perhaps the most striking advances are smart delivery systems that exploit ROS themselves as triggers. ROS-responsive hydrogels release their cargo only where and when oxidative stress flares, carrying antioxidants, neurotrophic factors, anti-inflammatory drugs, or gene therapies. One such system delivers engineered extracellular vesicles loaded with PINK1 mRNA that specifically target receptors on senescent Schwann cells, activating mitophagy to clear damaged mitochondria and reverse senescence. Another releases hydrogen sulfide in response to high ROS, simultaneously activating the Nrf2/HO-1 antioxidant axis and suppressing NF-κB-mediated inflammation. Engineered exosome platforms, magnetothermal release systems that activate TRPV1 channels to spur Schwann cell migration, and 4D bioprinted conduits that self-roll around injured nerves within seconds round out a toolkit that shifts nerve repair from passive support to active microenvironmental reprogramming.

The authors are candid about the distance to the clinic. Most current strategies act indirectly on the Schwann cell–ROS axis, no clinical trials yet directly target the interaction between the two, and the smartest systems face substantial barriers in long-term stability, scalable production, and standardized material benchmarks. Yet the trajectory is clear: by mapping how ROS dynamics govern Schwann cell fate—from mitochondrial electron leakage and reverse electron transport during reperfusion to ferroptosis and senescence—the field now possesses the mechanistic blueprint for intelligent neural repair systems that sense their chemical surroundings and respond in real time. If those systems mature, precise regeneration between peripheral nerves and their target organs could move from aspiration to routine practice, reducing the complications that currently condemn many injured nerves to permanent dysfunction.

Subject of Research: The dual role of reactive oxygen species in Schwann cell function and peripheral nerve regeneration

Article Title: The interaction between oxidative stress and Schwann cells

Article References: Yang, S., Zhang, Z., Liao, Q., Ouyang, Q., Ye, Y., Lu, W., & Jiang, Z. (2026). The interaction between oxidative stress and Schwann cells. Experimental Biology and Medicine, 251, Article 11146. https://doi.org/10.3389/ebm.2026.11146

Image Credits: AI Generated

DOI: 10.3389/ebm.2026.11146

Keywords: Schwann cells, reactive oxygen species, oxidative stress, peripheral nerve injury, nerve guidance conduits, ferroptosis, neural tissue engineering, mitophagy, Nrf2 pathway, drug delivery systems, 4D bioprinting, nerve regeneration

The study, published in Materials Today Bio, was led by Wenbi Wu and Maling Gou and centers on a modified form of gelatin known as gelatin methacryloyl, or GelMA. Rather than using conventional GelMA, which forms a relatively static network once crosslinked, the researchers devised a way to make the material dynamic. GelMA was first self-assembled into nanodroplets dispersed within a Pluronic F68 solution, and then locked into a solid hydrogel through rapid photopolymerization under visible light. The result is a scaffold built from interconnected GelMA nanoparticles, roughly 500 to 700 nanometers across, separated by continuous micron-sized pores. Under the microscope, the network looks open and sponge-like, an architecture that supports cell infiltration and the transport of nutrients and oxygen deep within the matrix.

The key innovation lies in how the team tuned the material’s behavior. By blending GelMA with two different degrees of methacrylate substitution, one highly crosslinked at 98 percent and one lightly crosslinked at 50 percent, they produced three formulations with progressively looser networks. Rheological testing revealed that the loss modulus of these hydrogels showed pronounced frequency dependence, a signature of dynamic, rearrangeable networks. The loosest formulation, Nano-GelMA3, proved the most permissive: it had the highest porosity and swelling capacity, the lowest stiffness, and the fastest enzymatic degradation in collagenase solution. In other words, it behaved less like a rigid barrier and more like a temporary, yielding matrix that cells could push through and remodel.

Laboratory experiments demonstrated just how responsive the material is. When Schwann cells, the glial cells that act as first responders after nerve injury, were embedded in the hydrogels, they spread rapidly, proliferated vigorously, and in time-lapse imaging were seen physically deforming the surrounding nanostructure as they moved. In conventional GelMA gels, cells remained largely spherical and the matrix barely changed. In the nanostructured gels, cells and matrix engaged in a visible dialogue: the cells pulled, the network yielded, and the local architecture reorganized to accommodate them. Schwann cells seeded on the surface of a three-millimeter-thick Nano-GelMA3 block migrated through its entire depth within 72 hours, a net displacement of roughly one millimeter per day, even under a gradient of nerve growth factor mimicking the physiological cue at an injury site.

The molecular basis of this behavior points to mechanotransduction, the process by which cells convert physical cues into biochemical signals. Immunostaining showed that Schwann cells in the nanostructured gels formed far more focal adhesions, the molecular anchors connecting cells to their surroundings. Levels of paxillin, phosphorylated focal adhesion kinase, and vinculin, all core components of the adhesion machinery, were significantly elevated compared with cells in conventional gels. Quantitative PCR revealed upregulation of integrin beta, Rac1, and Cdc42, regulators of cytoskeletal dynamics and cell-matrix signaling. The cells also expressed higher levels of nerve growth factor, myelin basic protein, and myelin protein zero, suggesting a phenotype primed for supporting axons and rebuilding myelin sheaths. The authors are careful to note that these findings are associative rather than proof of a single causal signaling pathway, but the pattern is consistent with a matrix that actively coaches cells into a regenerative state.

To turn the hydrogel into an implantable device, the team built a dual-layer conduit. The inner wall is an electrospun polycaprolactone tube about 300 micrometers thick, providing tensile strength, while the outer layer is a roughly 100-micrometer F127DA hydrogel shell printed directly onto the tube by digital light processing. The resulting conduit withstood a two-newton compressive force and sprang back to its original shape, while suture retention tests confirmed it could survive surgical handling. Filled with Nano-GelMA3, the complete device, dubbed PFNC, was biocompatible with Schwann cells in extraction assays and maintained its channel structure throughout the study period.

The decisive test came in rats with ten-millimeter sciatic nerve defects. Seven days after implantation, longitudinal sections of the regenerated tissue told a striking story. In conduits filled with the adaptive hydrogel, Schwann cells had infiltrated and occupied the entire luminal matrix, forming organized cellular populations from the proximal stump deep into the conduit. In hollow control conduits, cells clustered sparsely near the proximal end, waiting for a fibrin network to form before they could advance. By 24 days, the hydrogel-filled conduits contained continuous, aligned bridges of axons and Schwann cells spanning the gap, with significantly greater NF200-positive axonal extension and bridge coverage than the hollow controls. Histology at 14 days showed regenerating neural tissue growing within the residual hydrogel, confirming that the material facilitated rather than blocked tissue ingrowth, and the loosest formulation degraded progressively in vivo, clearing space as the new tissue took over.

Twelve weeks after surgery, the functional results were remarkable. Electrophysiological recordings showed that the compound muscle action potential latency in the hydrogel-filled conduit group, at 1.32 milliseconds, was significantly better than the hollow conduit group and statistically indistinguishable from the autograft group. Nerve conduction velocity reached 36.42 meters per second, again approaching the autograft benchmark of 41 meters per second. The gastrocnemius muscles served by the repaired nerves regained wet weight and fiber diameter comparable to the autograft group, evidence that the regenerated nerves were genuinely re-innervating their targets. Under the transmission electron microscope, regenerated myelinated fibers in the hydrogel group averaged 3.79 micrometers in diameter with myelin sheaths 0.55 micrometers thick, both essentially matching the autograft values. Histological examination found no necrosis, no severe inflammatory accumulation around the implant, and no pathological abnormalities in major organs.

What distinguishes this work from earlier attempts at nerve-filling hydrogels is the mechanism of adaptation. Most dynamic hydrogels respond to cell forces through the breaking and reforming of reversible molecular crosslinks, a process that allows gradual rearrangement at the molecular scale. The Nano-GelMA system instead adapts through wholesale reorganization of its nanoparticle network, permitting rapid, large deformations that open space for migrating cells, while the interconnected pores provide room for infiltration and nutrient flow. Notably, all of this was achieved without loading the material with exogenous growth factors or drugs; the physical architecture of the matrix alone was sufficient to recruit and activate the body’s own repair cells.

The road to the clinic still has checkpoints. The authors acknowledge that scalable manufacturing, batch-to-batch quality control of nanostructure and degradation, sterilization and storage protocols, and long-term assessment of residual material clearance and fibrosis all require further work. The precise mechanotransduction pathways engaged by the matrix also await confirmation through integrin-blocking and pathway-inhibition studies. Nevertheless, the central lesson of the study is already clear: a regenerative implant does not need to be a passive scaffold. By designing materials that yield, deform, and remodel in response to the cells they host, engineers can create an environment that meets the nervous system on its own terms, and in this rat model, that meeting produced recovery on par with the body’s best self-donated tissue.

Subject of Research: A cell-adaptive nanostructured GelMA hydrogel for engineering early regenerative microenvironments in peripheral nerve repair

Article Title: A cell-adaptive nanostructured hydrogel enables an early regenerative microenvironment for peripheral nerve repair

Article References: Wu, W., Zhu, Q., Dong, Y., Zhao, W., Peng, M., Zhang, Y., Zhang, J., Liu, H., Li, L., Liu, J., Zhang, L., Ren, Y., Luo, X., Li, B., Du, T., & Gou, M. (2026). A cell-adaptive nanostructured hydrogel enables an early regenerative microenvironment for peripheral nerve repair. Materials Today Bio, 41, Article 103725. https://doi.org/10.1016/j.mtbio.2026.103725

Image Credits: AI Generated

DOI: 10.1016/j.mtbio.2026.103725

Keywords: peripheral nerve repair, hydrogel, GelMA, Schwann cells, nerve guidance conduit, mechanotransduction, focal adhesion, nanotechnology, tissue engineering, 3D bioprinting, nerve regeneration, biomaterials

The study, published in BMC Plastic and Reconstructive Surgery, set out to answer a deceptively simple question: how large is the gap that forms the instant a healthy nerve is cut, before any swelling, scarring, or retraction of tissue can complicate the picture? The answer, measured across forty-four rat sciatic nerves, was an average of 4.0 millimeters, with individual gaps ranging from 2 to 6 millimeters and a standard deviation of 1.10 millimeters. Because the average diameter of the nerves at the transection site was 2.0 millimeters, the researchers concluded that the immediate gap is roughly twice the width of the nerve itself.

That ratio matters because the gap is produced purely by elastic recoil, the inherent springiness of nerve tissue, and not by any pathological process. The authors argue that this so-called time zero gap should be recognized as a normal finding rather than a defect that automatically demands a nerve graft. In an era when processed nerve allografts have become increasingly popular, and when some surgeons advocate grafting even freshly lacerated nerves to avoid any tension at the repair site, the distinction is clinically significant. Primary end-to-end repair has consistently produced better outcomes than any interposition graft, whether autograft or allograft, so the threshold for abandoning direct repair carries real consequences for patients.

The experimental design was deliberately minimalist. Twenty-two live male Sprague-Dawley rats, each weighing approximately 300 grams, were anesthetized with intraperitoneal ketamine and xylazine. All procedures were approved by the Columbia University Medical Center Institutional Animal Care and Use Committee, and a single surgeon performed every dissection under an operating microscope to eliminate variability between operators. The animals were positioned prone with their limbs secured close to the midline in a relaxed posture, a detail chosen specifically to minimize background tension on the sciatic nerve so that any gap measured afterward could be attributed to the nerve’s own elasticity rather than to body positioning.

Through blunt dissection at the plane between the quadriceps femoris and biceps femoris muscles, the surgeon exposed one centimeter of each sciatic nerve and carefully freed it from surrounding tissue without damaging its vessels or branches. The diameter of the nerve at the planned transection site was recorded with a ruler before a fresh scalpel blade divided the nerve at its midpoint, with a wooden spatula placed beneath it to shield underlying structures. After the spatula was withdrawn, the researchers took extreme care not to manipulate the nerve ends, then measured the distance between them. The primary outcome measure was simply that distance, captured at the moment of creation.

The statistical picture that emerged was strikingly consistent. Beyond the mean gap of 4.0 millimeters, the distribution of measured gaps clustered tightly around that value. Nerve diameters averaged 2.0 millimeters with a range of 1.0 to 2.0 millimeters and a standard deviation of 0.30 millimeters. Perhaps most interesting was what the correlation analysis did not show: the Pearson correlation coefficient between gap size and nerve diameter was just 0.093, a very weak positive relationship. In other words, thicker nerves did not reliably produce proportionally larger gaps in this sample, suggesting that the recoil behavior is governed by factors beyond simple geometry, possibly including the composition of the connective tissue within and around each nerve.

The clinical context for these numbers is a long-running debate over tension at nerve repair sites. Basic science has shown that acute stretching of a nerve compromises its blood flow and can impair regeneration, which is the physiological rationale for keeping repairs tension-free. Yet the same literature demonstrates that nerves can tolerate substantial gradual elongation, as limb and finger lengthening procedures prove. Work by Mackinnon and colleagues in a rat sciatic model showed that acute elongation to bridge a gap can be problematic, but that modest dissection to free up the nerve markedly reduces tension at the repair site. Surgeons also exploit a property called stress-relaxation: placing a few larger-caliber sutures to hold the nerve ends together and waiting a few minutes allows the tissue to stretch out, after which fine sutures can complete the repair under far less load.

Historical evidence leans further in favor of direct repair. In one of the few primate studies on the question, Hentz and colleagues repaired the ulnar nerves of Cynomolgus monkeys either end-to-end under tension or with interposition autografts under no tension, and the nerves repaired primarily under tension fared better. They concluded that for defects of up to three to four centimeters in adult humans, modest tension across a repair site is superior to achieving a tension-free repair with a graft. Against that backdrop, the new measurement of the time zero gap serves as a reminder that a visible gap immediately after injury is not evidence that the nerve is missing tissue; it is evidence that elastic tissue has sprung apart.

The authors offer a practical extrapolation. A human median nerve at the wrist has a diameter of roughly five millimeters, so if the two-to-one ratio holds, a fresh transection there would produce an instantaneous gap of about one centimeter. The team notes that they have clinically observed gaps exceeding one centimeter in acutely lacerated median and ulnar nerves, which is consistent with the rat data. Such a gap, seen in the emergency room or the operating theater within hours of injury, can look alarming and may prompt a decision toward allograft reconstruction. The study’s message is that this gap is usually recoverable through mobilization, joint positioning, and stress-relaxation techniques, and that a recent study by Jain and colleagues found nerve recoil did not appear to worsen over time, even as the window for primary repair of major nerves may be as short as two days.

The researchers are candid about the limitations of their work. They measured a single time point, so dynamic changes after injury, such as progressive retraction or early tissue remodeling, were not captured. The rat sciatic nerve, while a workhorse model in peripheral nerve research, differs from human nerves in diameter, connective tissue composition, and surrounding anatomy, all of which could influence how gaps develop in patients. The use of an analog rather than a digital ruler also leaves room for greater precision in future studies. The authors suggest that ethically feasible human data could be gathered during intentional neurotomies performed for denervation, nerve transfer, or neuroma treatment, procedures in which gaps form under controlled conditions. For now, the study establishes a baseline that has never existed before: cut a rat sciatic nerve and it will spring apart by twice its own width, a gap that primary repair can readily overcome and that, by itself, is no reason to reach for a graft.

Subject of Research: Quantification of the acute nerve gap produced by elastic recoil after rat sciatic nerve transection

Article Title: Time zero nerve gap created by rat sciatic nerve transection

Article References: Shukhmakher, E., Akelina, Y., & Strauch, R. J. (2025). Time zero nerve gap created by rat sciatic nerve transection. BMC Plastic and Reconstructive Surgery, 1(1), Article 5. https://doi.org/10.1186/s44452-025-00005-5

Image Credits: AI Generated

DOI: 10.1186/s44452-025-00005-5

Keywords: peripheral nerve injury, sciatic nerve, nerve transection, elastic recoil, nerve gap, nerve grafting, nerve allograft, primary nerve repair, microsurgery, rat model, nerve regeneration, tension at repair site